Top Markets
Coin of the day
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp.

KTTA
Rank in Stocks #35798
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the... Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Share Price
$0.46
Last synced: 2026-07-31
Market Cap
$3.42M
Change (1 day)
3.60%
Change (1 year)
-34.54%
Country
US
Trade Pasithea Therapeutics Corp. (KTTA)

Category

Operating Margin for Pasithea Therapeutics Corp. (KTTA)
Operating Margin as of 2026 TTM: 0.00%
According to Pasithea Therapeutics Corp. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Pasithea Therapeutics Corp. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.